Search results: “ATM”

Accelerate COVID-19 drug discovery & development programs targeting proinflammatory cytokines & others with qualified assays

Ensure long-term assay reproducibility with the production of bioassay cells — critical reagents for cell banks. Learn about custom scale-up…

Accelerate cancer immunotherapy drug development with easy-to-use, functional cell-based assays targeted at checkpoint receptors

Simple, non-radioactive, & dye-free cytotoxicity assays to specifically measure target cell death

Universal G-protein independent cell-based assays to quantify GPCR activation based on the recruitment of β-arrestin

Enzymes & cell-based functional, binding, & activity assays for kinase targets discovery through development & for QC lot-release testing

Assays to interrogate the MOA of GLP-1, GIP, and GCG receptors targeting therapeutics to accelerate obesity and type-2 diabetes drug…

Accelerate cancer immunotherapeutic discovery & development with cell-based, clinically relevant assays

Over 500 high-quality & purified recombinant kinases, phosphatases, & epigenetic & ubiquitin proteins

Interrogate a variety of popular target-specific signaling pathways with cell-based assays

Rapid cell-based assays for detecting protein turnover induced by targeted degrader molecules, such as PROTACs

Screening cell-based translocation assays for analyzing the movement of proteins to multiple membrane compartments within the cell